Clinical Trials Directory

Trials / Completed

CompletedNCT01241487

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

An 8 Weeks Open Label National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Novartis · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study is to assess the efficacy of the fixed combination of Valsartan and Amlodipine in hypertensive patients uncontrolled by monotherapy.

Conditions

Interventions

TypeNameDescription
DRUGvalsartan/amlodipine160/10 mg

Timeline

Start date
2009-02-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2010-11-16
Last updated
2017-02-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT01241487. Inclusion in this directory is not an endorsement.

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive (NCT01241487) · Clinical Trials Directory